Tags

Type your tag names separated by a space and hit enter

Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate.
Cardiovasc Diabetol. 2012 Sep 14; 11:108.CD

Abstract

BACKGROUND

All of the components of metabolic syndrome (MetS) have been regarded as risk factors for coronary artery disease (CAD). Early detection of CAD in asymptomatic patients with MetS remains a challenge. Cystatin C,which has been proposed as a novel marker of renal dysfunction,is correlated with mortality in CAD, The purpose of the study was to evaluate whether cystatin C is a potential marker of asymptomatic CAD in MetS patients with normal kidney function.

METHODS

A total of 211asymptomatic MetS patients without prior history of CAD patients were included in a cross-sectional study. Patients were divided into MetS with asymptomatic CAD (n=136) and MetS without CAD (n=75) groups according to coronary angiograph results. Serum cystatin C levels were measured using particle enhanced immunonephelometric assays. We first assessed whether there is an independent association of cystatin C with the presence and severity of asymptomatic CAD. Then, we investigated the association between cystatin C and other biochemical risk factors for atherosclerosis.

RESULTS

Serum cystatin C levels in patients with asymptomatic CAD were significantly higher than those without CAD (P=0.004). A multiple logistic regression analysis demonstrated cystatin C was independently associated with the presence of asymptomatic CAD (OR=1.326, 95%CI: 1.086-1.619). On receiver operating characteristics (ROC) analysis, the area under the curve (AUC) was 0.622 (95% CI: 0543-0.701, P=0.003), and cystatin C showed a moderate predictive value. Furthermore, cystatin C was independently correlated with Gensini score (standardized β=0.183, P=0.007), and serum cystatin C levels increased with the increasing of number of disease vessels (P=0.005). In a multiple stepwise regression analysis, uric acid (UA)(P<0.001), body mass index (BMI)(P=0.002), triglyceride(TG)(P=0.03), estimated glomerular filtration rate (eGFR)(P<0.001), and fibrinogen(P=0.001) were independently associated with cystatin C.

CONCLUSIONS

Serum cystatin C in our study was significantly associated with the presence and severity of asymptomatic CAD in MetS patients with normal kidney function, suggesting that cystatin C is probably more than a marker of glomerular filtration rate.

Authors+Show Affiliations

Department of Central Laboratory, Provincial Hospital affiliated to Shandong University, Jinan, People's Republic of China.No affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info availableNo affiliation info available

Pub Type(s)

Journal Article
Research Support, Non-U.S. Gov't

Language

eng

PubMed ID

22978689

Citation

Qing, Xie, et al. "Cystatin C and Asymptomatic Coronary Artery Disease in Patients With Metabolic Syndrome and Normal Glomerular Filtration Rate." Cardiovascular Diabetology, vol. 11, 2012, p. 108.
Qing X, Furong W, Yunxia L, et al. Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate. Cardiovasc Diabetol. 2012;11:108.
Qing, X., Furong, W., Yunxia, L., Jian, Z., Xuping, W., & Ling, G. (2012). Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate. Cardiovascular Diabetology, 11, 108. https://doi.org/10.1186/1475-2840-11-108
Qing X, et al. Cystatin C and Asymptomatic Coronary Artery Disease in Patients With Metabolic Syndrome and Normal Glomerular Filtration Rate. Cardiovasc Diabetol. 2012 Sep 14;11:108. PubMed PMID: 22978689.
* Article titles in AMA citation format should be in sentence-case
TY - JOUR T1 - Cystatin C and asymptomatic coronary artery disease in patients with metabolic syndrome and normal glomerular filtration rate. AU - Qing,Xie, AU - Furong,Wang, AU - Yunxia,Liu, AU - Jian,Zhang, AU - Xuping,Wang, AU - Ling,Gao, Y1 - 2012/09/14/ PY - 2012/06/27/received PY - 2012/08/21/accepted PY - 2012/9/18/entrez PY - 2012/9/18/pubmed PY - 2013/3/21/medline SP - 108 EP - 108 JF - Cardiovascular diabetology JO - Cardiovasc Diabetol VL - 11 N2 - BACKGROUND: All of the components of metabolic syndrome (MetS) have been regarded as risk factors for coronary artery disease (CAD). Early detection of CAD in asymptomatic patients with MetS remains a challenge. Cystatin C,which has been proposed as a novel marker of renal dysfunction,is correlated with mortality in CAD, The purpose of the study was to evaluate whether cystatin C is a potential marker of asymptomatic CAD in MetS patients with normal kidney function. METHODS: A total of 211asymptomatic MetS patients without prior history of CAD patients were included in a cross-sectional study. Patients were divided into MetS with asymptomatic CAD (n=136) and MetS without CAD (n=75) groups according to coronary angiograph results. Serum cystatin C levels were measured using particle enhanced immunonephelometric assays. We first assessed whether there is an independent association of cystatin C with the presence and severity of asymptomatic CAD. Then, we investigated the association between cystatin C and other biochemical risk factors for atherosclerosis. RESULTS: Serum cystatin C levels in patients with asymptomatic CAD were significantly higher than those without CAD (P=0.004). A multiple logistic regression analysis demonstrated cystatin C was independently associated with the presence of asymptomatic CAD (OR=1.326, 95%CI: 1.086-1.619). On receiver operating characteristics (ROC) analysis, the area under the curve (AUC) was 0.622 (95% CI: 0543-0.701, P=0.003), and cystatin C showed a moderate predictive value. Furthermore, cystatin C was independently correlated with Gensini score (standardized β=0.183, P=0.007), and serum cystatin C levels increased with the increasing of number of disease vessels (P=0.005). In a multiple stepwise regression analysis, uric acid (UA)(P<0.001), body mass index (BMI)(P=0.002), triglyceride(TG)(P=0.03), estimated glomerular filtration rate (eGFR)(P<0.001), and fibrinogen(P=0.001) were independently associated with cystatin C. CONCLUSIONS: Serum cystatin C in our study was significantly associated with the presence and severity of asymptomatic CAD in MetS patients with normal kidney function, suggesting that cystatin C is probably more than a marker of glomerular filtration rate. SN - 1475-2840 UR - https://www.unboundmedicine.com/medline/citation/22978689/Cystatin_C_and_asymptomatic_coronary_artery_disease_in_patients_with_metabolic_syndrome_and_normal_glomerular_filtration_rate_ L2 - https://cardiab.biomedcentral.com/articles/10.1186/1475-2840-11-108 DB - PRIME DP - Unbound Medicine ER -